Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,832 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effects of linagliptin vs. voglibose on daily glucose excursions during continuous glucose monitoring of Japanese type 2 diabetes patients (L-CGM): A randomized, open-label, two-arm, parallel comparative trial.
Satoh H, Ohira T, Moriya C, Inoue I, Kuribayashi S, Seino H, Hirai H, Hiyoshi T, Watada H; L-CGM Study Group. Satoh H, et al. Among authors: hirai h. Diabetes Metab. 2017 Dec;43(6):550-553. doi: 10.1016/j.diabet.2017.07.010. Epub 2017 Sep 22. Diabetes Metab. 2017. PMID: 28947255 Clinical Trial. No abstract available.
New risk prediction model of coronary heart disease in participants with and without diabetes: Assessments of the Framingham risk and Suita scores in 3-year longitudinal database in a Japanese population.
Hirai H, Asahi K, Yamaguchi S, Mori H, Satoh H, Iseki K, Moriyama T, Yamagata K, Tsuruya K, Fujimoto S, Narita I, Konta T, Kondo M, Shibagaki Y, Kasahara M, Watanabe T, Shimabukuro M. Hirai H, et al. Sci Rep. 2019 Feb 26;9(1):2813. doi: 10.1038/s41598-019-39049-w. Sci Rep. 2019. PMID: 30808962 Free PMC article.
Dissimilar Effects of Anagliptin and Sitagliptin on Lipoprotein Subclass in Standard or Strong Statin-Treated Patients with Type-2 Diabetes Mellitus: A Subanalysis of the REASON (Randomized Evaluation of Anagliptin versus Sitagliptin on Low-Density LipoproteiN Cholesterol in Diabetes) Trial.
Hirai H, Higa M, Morimoto T, Sakuma M, Arasaki O, Nomiyama T, Node K, Ueda S, Shimabukuro M. Hirai H, et al. J Clin Med. 2019 Dec 30;9(1):93. doi: 10.3390/jcm9010093. J Clin Med. 2019. PMID: 31905896 Free PMC article.
Rationale and design of an investigator-initiated, multicenter, prospective open-label, randomized trial to evaluate the effect of ipragliflozin on endothelial dysfunction in type 2 diabetes and chronic kidney disease: the PROCEED trial.
Tanaka A, Shimabukuro M, Okada Y, Sugimoto K, Kurozumi A, Torimoto K, Hirai H, Node K; PROCEED trial investigators. Tanaka A, et al. Among authors: hirai h. Cardiovasc Diabetol. 2020 Jun 13;19(1):85. doi: 10.1186/s12933-020-01065-w. Cardiovasc Diabetol. 2020. PMID: 32534578 Free PMC article.
Suboptimal diabetic control and psychological burden after the triple disaster in Japan: the Fukushima Health Management Survey.
Hirai H, Okazaki K, Ohira T, Maeda M, Sakai A, Nakano H, Hayashi F, Nagao M, Harigane M, Takahashi A, Ohira H, Kazama JJ, Hosoya M, Yabe H, Suzuki Y, Yasumura S, Ohto H, Kamiya K, Shimabukuro M. Hirai H, et al. BMJ Open Diabetes Res Care. 2021 Sep;9(1):e002007. doi: 10.1136/bmjdrc-2020-002007. BMJ Open Diabetes Res Care. 2021. PMID: 34497045 Free PMC article.
Influence of Maternal Active and Secondhand Smoking during Pregnancy on Childhood Obesity at 3 Years of Age: A Nested Case-Control Study from the Japan Environment and Children's Study (JECS).
Horiuchi S, Shinohara R, Otawa S, Kushima M, Akiyama Y, Ooka T, Kojima R, Yokomichi H, Miyake K, Hirai H, Hashimoto K, Shimabukuro M, Yamagata Z, Japan Environment And Children's Study Group. Horiuchi S, et al. Among authors: hirai h. Int J Environ Res Public Health. 2021 Nov 27;18(23):12506. doi: 10.3390/ijerph182312506. Int J Environ Res Public Health. 2021. PMID: 34886230 Free PMC article.
1,832 results